NCT00366366View on ClinicalTrials.gov

To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Infanrix-Hexa

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY